We’ve Been Shortlisted in the 2021 SelectScience Scientists' Choice Awards®

Laboratory scientists across the globe are invited to vote for their favorite clinical products of 2020. Here’s how.
We’ve Been Shortlisted in the 2021 SelectScience Scientists' Choice Awards®

The 2021 Scientists Choice Awards®

SelectScience’s annual Scientists' Choice Awards is celebrating its 14th anniversary by honoring the most innovative and effective technologies of the past year. The awards provide scientists worldwide with the opportunity to acknowledge the instruments, assays, tools, or consumables that have made the most difference to their work.

Thanks to our loyal customers, we’re delighted to announce the Access SARS-CoV-2 IgM assay > has been nominated in the Best New Clinical Assay/Kit of 2020 category.

Our high-sensitivity and high-specificity SARS-CoV-2 IgM assay > has market-leading accuracy with a high positive predictive value (PPV) and a high negative predictive value (NPV). This provides clinicians with useful immune response information and may help determine if their patients have had a recent COVID-19 infection.

Casting Your Vote

Voting closes Sunday, June 13, 2021. All scientists who cast their vote for their favorite clinical products of 2020 will be entered into a drawing for a chance to win a $500/£400/450 € Amazon Gift Card from SelectScience.

Interested in sharing your thoughts?

Editorial Team
Editorial Team
The Beckman Coulter editorial team brings you timely news and resources focused on elevating clinical laboratory performance and advancing patient care.

Related Articles

We’ve Been Shortlisted in the 2021 SelectScience Scientists' Choice Awards®

We’ve Been Shortlisted in the 2021 SelectScience Scientists' Choice Awards®

Laboratory scientists across the globe are invited to vote for their favorite clinical products of 2020. Here’s how.
Body Fluids Analysis with Linearity Down to Zero

Body Fluids Analysis with Linearity Down to Zero

Body fluid analysis is imperative for the diagnosis of many life-threatening diseases. Learn how to make the process more efficient for timely results.
Mass Antigen Testing: Alternatives to Efficient Diagnostic Testing During a Global Pandemic

Mass Antigen Testing: Alternatives to Efficient Diagnostic Testing During a Global Pandemic

Antigen testing provides an efficient, cost-effective way to mass test for COVID-19 which is essential for hospitals. learn how one laboratory is using this test in their daily operation.